News

  • Reset
female doctor with female patient

Mayne Pharma adds a generic PROTOPIC® to US portfolio

12 Jan 2022

Mayne Pharma Group Limited (ASX: MYX) is pleased to announce it has begun distribution of tacrolimus ointment, 0.1% in the United States

Learn more

Contraceptive Packet

TGA approval of novel oral contraceptive NEXTSTELLIS®

29 Nov 2021

Mayne Pharma Group Limited (ASX: MYX) and Mithra Pharmaceuticals, SA (Euronext Brussels: MITRA) are very pleased to announce the Therapeutic Goods Administration (TGA) has approved the novel combined oral contraceptive NEXTSTELLIS® (14.2 mg of estetrol and 3 mg drospirenone tablets).

Learn more

Mayne Pharma 2021 AGM Chairman's Address

2021 AGM Chairman’s Address

23 Nov 2021

Welcome everyone, I'm Frank Condella, the Chair of Mayne Pharma. It is a pleasure to welcome you to Mayne Pharma’s 2021 Annual General Meeting. As we have a quorum present, I am delighted to open the meeting

Learn more

Mayne Pharma 2021 AGM CEOs Speech

2021 AGM CEO’s Speech

23 Nov 2021

Today I will provide you with an update on the launch of NEXTSTELLIS our novel contraceptive which received FDA approval earlier this year together with some comments around our evolving specialty products business model and our outlook.

Learn more

Hands holding a Nuvaring

Mayne Pharma provides FDA update on generic NUVARING®

7 Oct 2021

Mayne Pharma Group Limited (ASX: MYX) has received a complete response letter (CRL) from the US Food and Drug Administration (FDA) in relation to its abbreviated new drug application (ANDA) for a generic version of NUVARING.

Learn more

Dr Carolyn Myers

Mayne Pharma appoints new Director

4 Oct 2021

Mayne Pharma Group Limited (ASX: MYX) is pleased to announce that Carolyn Myers, M.B.A., Ph.D. has accepted an invitation to join the Board of Mayne Pharma Group Limited, effective immediately

Learn more

Capsules

Generic ABSORICA® added to US portfolio

29 Sep 2021

Mayne Pharma Group Limited (ASX: MYX) is pleased to announce it has begun distribution of isotretinoin capsules, 10 mg, 20 mg, 30 mg and 40 mg in the United States.

Learn more

Woman's Hands With Foam

FDA Approves Lexette® for Adolescent Plaque Psoriasis

22 Sep 2021

Mayne Pharma is pleased to announce that the U.S. Food and Drug Administration (FDA) has approved LEXETTE® (halobetasol propionate) foam, 0.05% for use in adolescents.

Learn more

Financial,Data,Graph,Chart,,Vector,Illustration.,Abstract,Background,With,Graph

2021 Full Year Results Media Release

27 Aug 2021

2021 Full Year Results Media Release

Learn more